What makes Susane Njomo, DNP, at Prima Urgent Care, the right choice to guide you on how long Semaglutide GLP-1 takes to suppress appetite
Patients considering Mounjaro should discuss with their GP or diabetes specialist whether this therapy is appropriate for their individual circumstances, taking into account their treatment history, comorbidities, and personal preferences
The FDA advisory on GLP-1s specifically mentions medullary thyroid cancer
Key takeaway: Retatrutide delivers 24.2% weight loss (versus 14.9% for Wegovy and 20.9% for Zepbound) while maintaining a side effect profile thats actually better than Wegovy in several categories
It should only be used under the supervision of a licensed provider
They differ significantly in mechanism, clinical evidence, and design